Site icon Resources to support community and institutional Long-Term Care responses to COVID-19

The impact of the COVID-19 pandemic on people with learning disabilities across the UK – latest findings from Wave 2

Chris Hatton (Manchester Metropolitan University), Richard Hastings (University of Warwick) and the Project Team*

The Coronavirus and Learning Disability Study has been tracking the experiences of adults with learning disabilities through the COVID-19 pandemic over time across the four UK nations. Wave 1 data were collected between December 2020 and February 2021, mostly at a time of UK-wide lockdown and before COVID-19 vaccines were prioritised for all adults with learning disabilities (see here for Wave 1 findings). Here we report on findings from Wave 2 of the project, where we heard from people during April and May 2021 when restrictions were being eased and COVID-19 vaccination was up and running for adults with learning disabilities.

There are two cohorts of participants in this project.

This blog presents a selection of the findings from Wave 2 of the project, which we released in June and July 2021 as a series of briefings with accompanying Easy Read versions (the briefings can be found here). The findings cover a wide range of issues relating to people’s circumstances and experiences of the COVID-19 pandemic – this blog highlights a selection of the findings potentially relevant to social care.

COVID-19

COVID-19 vaccination

Managing COVID-19 risk at home

Managing COVID-19 risk outside the home

Health and social care support

Digital lives

Carers

What happens next?

Following extensive work by and with collaborating organisations across the UK, the Wave 3 interviews and surveys have started in July for people who took part in the Wave 1 and/or Wave 2 interviews and surveys. More details are available on our project website and through social media:

Twitter: @CoronavirusLD

Instagram: coronavirusLD

Project teams and acknowledgements:

*Sue Caton (Manchester Metropolitan University); Samantha Flynn, Nikita Hayden and Andreas Paris (University of Warwick); Anna Marriott (NDTi); Andrew Jahoda, Amanda Gillooly and Roseann Maguire (University of Glasgow); Laurence Taggart and Peter Mulhall (University of Ulster); Stuart Todd and Edward Oloidi (University of South Wales); Jill Bradshaw and Nick Gore (University of Kent); Stephen Beyer (Cardiff University); Katrina Scior (UCL); David Abbott and Pauline Heslop (University of Bristol)

This research was funded by UK Research and Innovation (Medical Research Council), and supported by the Department for Health and Social Care (National Institute for Health Research) as part of the UKRI-DHSC COVID-19 Rapid Response Rolling Call.

This document contains the results from independent research funded by the Department for Health and Social Care (DHSC) (National Institute for Health Research; NIHR) and UK Research and Innovation (UKRI) (Medical Research Council; MRC). The views expressed in this document are those of the author(s) and not necessarily those of DHSC, NIHR, UKRI or MRC.